Spots Global Cancer Trial Database for Efficacy and Safety of Cinacalcet in Ca, P and iPTH Levels in Patients With Mild, Moderate and Severe SHPT
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Efficacy and Safety of Cinacalcet in Ca, P and iPTH Levels in Patients With Mild, Moderate and Severe SHPT
Official Title: A Multi-center Study Evaluating Efficacy and Safety of Cinacalcet Hydrochloride(HCL) in Calcium, Phosphorus and Intact Parathyroid Hormone(iPTH) Serum Levels in Chinese Chronic Kidney Disease(CKD) Hemodialysis(HD) Patients With Mild, Moderate and Severe Secondary Hyperparathyroidism(SHPT)
Study ID: NCT03123406
Conditions
Interventions
Study Description
Brief Summary: 1. To evaluate achievement ratio of iPTH,Calcium and phosphorus after taking Cinacalcet HCL in hemodialysis subjects with mild, moderate and severe SHPT; 2. To explore the impact of Cinacalcet HCL using on the combined use of drugs; 3. To explore the difference of patients who continued or discontinued Cinacalcet HCL in real-world period from 33rd to 52nd week.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Nanjing Jinling Hospital, Nanjing, Jiangsu, China
Contact Details
Name: Zhihong Liu
Affiliation: Jinling Hospital, China
Role: STUDY_CHAIR
Name: Zhaohui Ni
Affiliation: RenJi Hospital
Role: PRINCIPAL_INVESTIGATOR
Name: Zhangsuo Liu
Affiliation: The First Affiliated Hospital of Zhengzhou University
Role: PRINCIPAL_INVESTIGATOR
Name: Jiazhuang Lou
Affiliation: The First Affiliated Hospital with Nanjing Medical University
Role: PRINCIPAL_INVESTIGATOR
Name: Guanqing Xiao
Affiliation: First People's Hospital of Foshan
Role: PRINCIPAL_INVESTIGATOR
Name: Li Hao
Affiliation: The Second Hospital of Anhui Medial University
Role: PRINCIPAL_INVESTIGATOR
Name: Ping Fu
Affiliation: West China Hopsital, Sichuan University
Role: PRINCIPAL_INVESTIGATOR
Name: Yisheng Ling
Affiliation: Zhongshan Hospital Xiamen University
Role: PRINCIPAL_INVESTIGATOR
Name: Xuemei Li
Affiliation: Peking Union Medical College Hospital
Role: PRINCIPAL_INVESTIGATOR
Name: Shixiang Wang
Affiliation: Beijing Chao Yang Hospital
Role: PRINCIPAL_INVESTIGATOR
Name: Aihua Zhang
Affiliation: Peking University Third Hospital
Role: PRINCIPAL_INVESTIGATOR
Name: Xiaonong Chen
Affiliation: Ruijin Hospital
Role: PRINCIPAL_INVESTIGATOR
Name: Jing Chen
Affiliation: Huashan Hospital
Role: PRINCIPAL_INVESTIGATOR
Name: Li Zuo
Affiliation: Peking University People's Hospital
Role: PRINCIPAL_INVESTIGATOR
Name: Aili Jiang
Affiliation: Tianjin Medical University Second Hospital
Role: PRINCIPAL_INVESTIGATOR
Name: Guohua Ding
Affiliation: Hubei General Hospital
Role: PRINCIPAL_INVESTIGATOR
Name: Jianying Niu
Affiliation: The Fifth People's Hospital of Shanghai, Fudan University
Role: PRINCIPAL_INVESTIGATOR
Name: Yonghui Mao
Affiliation: Beijing Hospital
Role: PRINCIPAL_INVESTIGATOR
Name: Qiang He
Affiliation: Sichuan Provincial People's Hospital
Role: PRINCIPAL_INVESTIGATOR
Name: Chaosheng Chen
Affiliation: First Affiliated Hospital of Wenzhou Medical University
Role: PRINCIPAL_INVESTIGATOR
Name: Hong Liu
Affiliation: Second Xiangya Hospital of Central South University
Role: PRINCIPAL_INVESTIGATOR
Name: Junwei Yang
Affiliation: Second Affiliated Hospital of Nanjing Medical University
Role: PRINCIPAL_INVESTIGATOR
Name: Jianming Ye
Affiliation: The First People's Hospital of Kunshan
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
